Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

A Prospective Study and Identification of Genomewide Association Markers of Familial Predisposition to Plasma Cell Dyscrasias

Adam S Sperling, MD PhD, Rebecca Georgakopoulou, MSc, Mehmet Kemal Samur, PhD, Christine Ivy Liacos, MSc, Brittany E Sandoval, MSc, Flora Zagouri, MD, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, MD, Magdalini Migkou, Nikolaos Kanellias, MD, Despina Fotiou, BMBS, MA, Ioannis Ntanasis-Stathopoulos, MD, Evangelos Terpos, MDPhD, Efstathios Kastritis, MD, Nikhil C. Munshi, MD, Meletios A Dimopoulos

Blood (2020) 136 (Supplement 1): 8.

https://doi.org/10.1182/blood-2020-137337

Published: 2020

Journal Articles

Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma

Vassilis Koutoulidis, Evangelos Terpos, MD PhD, Ioannis Ntanasis-Stathopoulos, Flora Zagouri, Ioanna Klapa, Andriani Boultadaki, Maria Gavriatopoulou, Sophia Fontara, Eftathios Kastritis, Meletios A. Dimopoulos, Lia A. Moulopoulos

Blood (2017) 130 (Supplement 1): 4404.

https://doi.org/10.1182/blood.V130.Suppl_1.4404.4404

Published: 2017

Journal Articles

Lenalidomide, Adriamycin, and Dexamethasone (RAD) As Induction Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Eligible for Autologous Transplantation (ASCT): A Phase 2 Study from the Greek Myeloma Study Group

Evangelos Terpos, Eirini Katodritou, Argiris Symeonidis, Flora Zagouri, Antonis Gerofotis, Georgia Christopoulou, Maria Gavriatopoulou, Dimitrios Christoulas, Alexandra Kourakli, Pavlina Konstantinidou, Efstathios Kastritis, MD, Meletios A Dimopoulos

Blood (2016) 128 (22): 4488.

https://doi.org/10.1182/blood.V128.22.4488.4488

Published: 2016

Journal Articles

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Efstathios Kastritis, MD, Evangelos Terpos, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Fotiou, Dimitra Gika, Despoina Kalapanida, Eftychia Kafantari, Maria Roussou, Flora Zagouri, Stavroula Giannouli, Athanasios Zomas, Kostas Konstantopoulos, Meletios A. Dimopoulos

Blood (2015) 126 (23): 3045.

https://doi.org/10.1182/blood.V126.23.3045.3045

Published: 2015

Journal Articles

Diffusion-Weighted Imaging Improves Accuracy in the Diagnosis of MRI Patterns of Marrow Involvement in Newly Diagnosed Myeloma: Results of a Prospective Study in 99 Patients

Evangelos Terpos, Vassilis Koutoulidis, Sofia Fontara, Flora Zagouri, Dimitrios Christoulas, Dimitris Matsaridis, Andreas Koureas, Efstathios Kastritis, MD, Meletios A. Dimopoulos, Lia A. Moulopoulos

Blood (2015) 126 (23): 4178.

https://doi.org/10.1182/blood.V126.23.4178.4178

Published: 2015

Journal Articles

Newly Diagnosed Multiple Myeloma Is Associated with Enhanced TF Pathway Activation, Thrombin Generation and Increased Concentration of Procoagulant Microparticles

Grigorios T. Gerotziafas, Dr, Flora Zagouri, Despina Fotiou, Theodoros N. Sergentanis, Kimon Stamatelopoulos, Theodora Psaltopoulou, Efstathios Kastritis, MD, Evangelos Terpos, MD, Patrick Van Dreden, PhD, Aurélie Rousseau, Ilias Evmorfiadis, Ismail Elalamy, MDPhD, Annette Larsen, Meletios A. Dimopoulos

Blood (2015) 126 (23): 1074.

https://doi.org/10.1182/blood.V126.23.1074.1074

Published: 2015

Journal Articles

Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Is Able to Distinguish Diffuse from Normal MRI Pattern of Marrow Involvement in Patients with Multiple Myeloma

Evangelos Terpos, Vassilis Koutoulidis, Sofia Fontara, Flora Zagouri, Dimitris Matsaridis, Dimitrios Christoulas, Andreas Koureas, Efstathios Kastritis, MD, Meletios A. Dimopoulos, Lia A. Moulopoulos

Blood (2014) 124 (21): 3461.

https://doi.org/10.1182/blood.V124.21.3461.3461

Published: 2014

Journal Articles

Preserved Levels Of Uninvolved Immunoglobulins Are Associated With Better Overall Survival In Patients With Multiple Myeloma Independently Of Disease Burden: A Role For The Immune System?

Blood (2013) 122 (21): 1866.

https://doi.org/10.1182/blood.V122.21.1866.1866

Published: 2013

Journal Articles

IgD Myeloma: Clinical Features and Outcome In The Era Of Novel Agents

Flora Zagouri, Efstathios Kastritis, Argiris S. Symeonidis, Nikolaos Giannakoulas, Eirini Katodritou, Sosana Delimpasi, Panagiotis Repousis, Stavroula Giannouli, Eudokia M. Mandala, Evangelos Terpos, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 1935.

https://doi.org/10.1182/blood.V122.21.1935.1935

Published: 2013

Journal Articles

Lenalidomide Administration In Patients With POEMS Syndrome

Flora Zagouri, Efstathios Kastritis, Maria Gavriatopoulou, Theodora Psaltopoulou, Theodoros N. Sergentanis, Evangelos Terpos, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3235.

https://doi.org/10.1182/blood.V122.21.3235.3235

Published: 2013

Journal Articles

Reversibility of Renal Impairment of Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Identification of Predictive Factors.

Meletios A. Dimopoulos, Maria Roussou, Efstathios Kastritis, Maria Gavriatopoulou, Flora Zagouri, Magdalini Migkou, Charis Matsouka, Despina Barmparousi, Dimitrios Christoulas, Erasmia Psimenou, Irini Grapsa, Evangelos Terpos

Blood (2008) 112 (11): 1725.

https://doi.org/10.1182/blood.V112.11.1725.1725

Published: 2008

Journal Articles

Treatment of Patients with Relapsed/Refractory Multiple Myeloma (MM) with Lenalidomide and Dexamethasone with or with Bortezomib Depending on Prior Neurotoxicity: Prospective Evaluation of the Impact of Cytogenetic Abnormalities and Assessment of Bone Met.

Meletios A. Dimopoulos, Efstathios Kastritis, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Flora Zagouri, Evangelos Terpos

Blood (2008) 112 (11): 1726.

https://doi.org/10.1182/blood.V112.11.1726.1726

Published: 2008

Journal Articles

Phase I/II Study of Lenalidomide, Intermediate Dose Dexamethasone and Low Dose Cyclophosphamide (RDC) for the Treatment of Patients with Primary Systemic Amyloidosis (AL).

Efstathios Kastritis, Flora Zagouri, Maria Roussou, Magdalini Migkou, John Boletis, Theofanis Apostolou, Meletios A. Dimopoulos

Blood (2008) 112 (11): 1734.

https://doi.org/10.1182/blood.V112.11.1734.1734

Published: 2008

Journal Articles

Immunoexpression of Macrophage Inflammatory Protein-1 Alpha on Bone Marrow Trephine Biopsies Correlates with the Extent of Bone Disease in Newly Diagnosed Patients with Multiple Myeloma

Maria Roussou, Anna Tasidou, Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Flora Zagouri, Meletios A. Dimopoulos, Evangelos Terpos

Blood (2008) 112 (11): 5119.

https://doi.org/10.1182/blood.V112.11.5119.5119

Published: 2008

NARROW

A Prospective Study and Identification of Genomewide Association Markers of Familial Predisposition to Plasma Cell Dyscrasias

Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma

Lenalidomide, Adriamycin, and Dexamethasone (RAD) As Induction Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Eligible for Autologous Transplantation (ASCT): A Phase 2 Study from the Greek Myeloma Study Group

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Diffusion-Weighted Imaging Improves Accuracy in the Diagnosis of MRI Patterns of Marrow Involvement in Newly Diagnosed Myeloma: Results of a Prospective Study in 99 Patients

Newly Diagnosed Multiple Myeloma Is Associated with Enhanced TF Pathway Activation, Thrombin Generation and Increased Concentration of Procoagulant Microparticles

Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Is Able to Distinguish Diffuse from Normal MRI Pattern of Marrow Involvement in Patients with Multiple Myeloma

Preserved Levels Of Uninvolved Immunoglobulins Are Associated With Better Overall Survival In Patients With Multiple Myeloma Independently Of Disease Burden: A Role For The Immune System?

IgD Myeloma: Clinical Features and Outcome In The Era Of Novel Agents

Lenalidomide Administration In Patients With POEMS Syndrome

Reversibility of Renal Impairment of Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Identification of Predictive Factors.

Treatment of Patients with Relapsed/Refractory Multiple Myeloma (MM) with Lenalidomide and Dexamethasone with or with Bortezomib Depending on Prior Neurotoxicity: Prospective Evaluation of the Impact of Cytogenetic Abnormalities and Assessment of Bone Met.

Phase I/II Study of Lenalidomide, Intermediate Dose Dexamethasone and Low Dose Cyclophosphamide (RDC) for the Treatment of Patients with Primary Systemic Amyloidosis (AL).

Immunoexpression of Macrophage Inflammatory Protein-1 Alpha on Bone Marrow Trephine Biopsies Correlates with the Extent of Bone Disease in Newly Diagnosed Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only